Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2010
09/30/2010CA2755976A1 Methods of treatment using combination therapy
09/30/2010CA2755953A1 Novel aminopyridine derivatives having aurora a selective inhibitory action
09/30/2010CA2755910A1 Inhibitors of nf-kb
09/30/2010CA2755810A1 Novel aminopyridine derivatives having aurora a selective inhibitory action
09/30/2010CA2755806A1 Novel aminopyridine derivatives having aurora a selective inhibitory action
09/30/2010CA2755768A1 P2x3, receptor antagonists for treatment of pain
09/30/2010CA2755680A1 P2x3, receptor antagonists for treatment of pain
09/30/2010CA2755658A1 Fused ring inhibitors of hepatitis c
09/30/2010CA2755348A1 Antiviral compounds and uses thereof
09/30/2010CA2755196A1 Diaminopteridine derivatives
09/30/2010CA2755023A1 Antiviral compounds and uses thereof
09/30/2010CA2754684A1 Calcium citrate and calcium lactate formulations for alteration of biophysical properties of mucosal lining
09/30/2010CA2754670A1 Anti-influenza formulations and methods
09/30/2010CA2754642A1 5-.beta., 14-.beta.-androstane derivatives useful for the treatment of proteinuria, glomerulosclerosis and renal failure
09/30/2010CA2754416A1 Novel medicament for treating cognitive impairment
09/30/2010CA2754184A1 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010CA2754176A1 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010CA2754154A1 Method for the industrial purification of biologically active phycotoxins
09/30/2010CA2753868A1 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
09/30/2010CA2660962A1 Novel pharmaceutical composition for treatment of schizophrenia
09/30/2010CA2660954A1 Novel salt of 1,3,5-triazine-2,4,6-triamine derivative
09/29/2010EP2233572A2 Genes and polypeptides relating to human colon cancers
09/29/2010EP2233494A1 Riboswitches, methods for their use, and compositions for use with riboswitches
09/29/2010EP2233493A1 Macrolides
09/29/2010EP2233487A1 Spirocyclic cyclohexane derivatives
09/29/2010EP2233486A1 Azaindoles
09/29/2010EP2233484A2 Oxazolidinone derivatives having a 7-membered heterocyclic ring
09/29/2010EP2233483A1 Indole or Benzimidazole derivatives as IkB-kinase modulators and intermediates in their preparation.
09/29/2010EP2233482A1 A crystalline variable hydrate of (s)-6-(4-(2-((3-(9h-carbazol-4-yloxy)-2-hydroxypropyl)amino)-2-methylpropyl)phenoxy)-3-pyridinecarboxamide hemisuccinate salt
09/29/2010EP2233480A1 Chemical compounds
09/29/2010EP2233479A1 Dispiro tetraoxane compounds and their use in the treatment of malaria and/or cancer
09/29/2010EP2233474A1 Condensed aminodihydrothiazine derivative
09/29/2010EP2233473A1 3,5-di(aryl or heteroaryl)isoxazoles and 1,2,4-oxadiazoles as S1P1 receptor agonists, immunosuppresssive and anti-inflammatory agents
09/29/2010EP2233472A1 Heterocyclic compounds and uses thereof in the treatment of sexual disorders
09/29/2010EP2233471A1 A salt of 7-{4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy}-3,4.dihydro-2(1h)-quinolinone with 5-sulfosalicylic acid and its preparation process
09/29/2010EP2233470A1 Histamine H3 receptor antagonists
09/29/2010EP2233467A1 Alpha-amino-n-substituted amides, pharmaceutical composition containing them and uses thereof
09/29/2010EP2233465A1 Preparation method of rivastigmine, its intermediates and preparation method of the intermediates
09/29/2010EP2233463A1 New compounds isolated from extract of antrodia camphorata
09/29/2010EP2233174A1 Compositions and use of tyrosine kinase inhibitors to treat pathogenic infection
09/29/2010EP2233157A1 A biocompatible denatured starch sponge material
09/29/2010EP2233156A2 Use of aprotinin polypeptides as carriers in pharmaceutical conjugates
09/29/2010EP2233155A2 Therapeutic polyanhydride compounds for drug delivery
09/29/2010EP2233154A1 Skin external preparation
09/29/2010EP2233147A1 Salt solution for colon cleansing
09/29/2010EP2233145A1 A dose of AVE5026 for the treatment of venous thromboembolism in patients with severe renal impairment
09/29/2010EP2233144A1 Chitosan-containing compositions and process for production thereof
09/29/2010EP2233143A1 Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
09/29/2010EP2233142A1 Transdermally absorptive preparation
09/29/2010EP2233141A1 Ppharmaceutical compositions coprising polymorphic forms of dehydroepiandrosterone
09/29/2010EP2233140A1 Bicyclic amides for enhancing glutamatergic synaptic responses
09/29/2010EP2233139A1 Minoxidil aqueous composition containing bile acid
09/29/2010EP2233138A1 Tape preparation comprising etodolac in ionic liquid form
09/29/2010EP2233137A2 Calcium receptor activator
09/29/2010EP2233136A1 Use of HPPD Inhibitors in the Treatment of Depression and/or Withdrawal Symptoms Associated with Addictive Drugs
09/29/2010EP2233135A1 Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas
09/29/2010EP2233133A1 Stable Rosuvastatin Compositions
09/29/2010EP2233131A1 Pharmaceutical composition containing levodopa, entacapone and carbidopa
09/29/2010EP2233130A1 A sustained release oral composition of an antipsychotic agent
09/29/2010EP2233129A1 Oral cavity disintegrating tablet and method of producing the same
09/29/2010EP2231690A2 Clofarabine dietherphospholipid derivatives
09/29/2010EP2231689A1 Novel cytostatic 7-deazapurine nucleosides
09/29/2010EP2231688A1 Non-hydrolyzable nucleoside di- or tri-phosphate derivatives and uses thereof
09/29/2010EP2231687A2 Novel derivatives of acyl cyanopyrrolidines
09/29/2010EP2231684A1 Compounds and methods for the treatment of cancer
09/29/2010EP2231677A2 Trisubstituted piperidines as renin inhibitors
09/29/2010EP2231676A1 (e)-n-{3-[1-(8-fluoro-11h-10-oxa-1-aza-dibenzo[a,d]-cycl0hepten-5ylidene)-propyl]-phenyl }-methynsulfon amide as glucocorticoid receptor modulator for the treatment of rheumatoid
09/29/2010EP2231673A1 Method for the preparation of morphine compounds
09/29/2010EP2231672A1 Biaryl substituted diazabicycloalkane derivatives
09/29/2010EP2231671A1 Modulators of cystic fibrosis transmembrane conductance regulator
09/29/2010EP2231669A1 Phosphodiesterase inhibitors
09/29/2010EP2231668A1 Condensed pentacyclic derivatives for use in the treatment of flaviviridae infections
09/29/2010EP2231667A2 Beta-lactamase inhibitors
09/29/2010EP2231666A1 Carboxamide, sulfonamide and amine compounds for metabolic disorders
09/29/2010EP2231664A1 4-(pyrroloý2,3-c¨pyridine-3-yl)-pyrimidine-2-amine derivatives
09/29/2010EP2231663A2 Fused heterocyclic derivatives and methods of use as c-met inhibitors
09/29/2010EP2231662A1 8-anilin0imidaz0pyridines and their use as anti-cancer and/or anti-inflammatory agents
09/29/2010EP2231661A1 Inhibitors of pi3 kinase
09/29/2010EP2231660A1 Imidazo [1,2-a] pyridine compounds
09/29/2010EP2231659A1 Translocator protein ligands
09/29/2010EP2231657A1 Biaryl substituted azabicyclic alkane derivatives as nicotinic acetylcholine receptor activity modulators
09/29/2010EP2231656A1 Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors
09/29/2010EP2231655A2 4(-3-(-2-(phenyl)morpholino)-2-oxopyrrolidin-1-yl)-n-(thiazol-2-yl)benzenesulfonamide derivati ves and related compounds as modulators of ion channels for the treatment of pain
09/29/2010EP2231654A1 Novel 2-substituted thiazole-4-carboxamide derivatives, production thereof, and use thereof as a medicament
09/29/2010EP2231653A1 Antibacterial condensed thiazoles
09/29/2010EP2231652A1 Novel 2-hetaryl thiazole-4-carboxamide derivatives, production thereof, and use thereof as a medicament
09/29/2010EP2231651A1 Isoxazolo-pyridazine derivatives
09/29/2010EP2231650A1 Isoxazole derivatives as modulators of 11-beta-hydroxysteroid dehydrogenase type 1
09/29/2010EP2231649A1 Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
09/29/2010EP2231648A1 New salts and crystal forms
09/29/2010EP2231646A1 Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists
09/29/2010EP2231645A2 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases
09/29/2010EP2231644A2 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases
09/29/2010EP2231643A1 Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
09/29/2010EP2231642A1 Pyrimidines as kinase inhibitors
09/29/2010EP2231641A2 Quinoxaline and quinoline derivatives as kinase inhibitors
09/29/2010EP2231640A1 Beta-amino acid derivatives for treatment of diabetes
09/29/2010EP2231639A1 Crystalline forms of n-(tert-butoxycarbonyl)-3-methyl-l-valyl-(4r)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-n-((1r,2s)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-l-prolinamide
09/29/2010EP2231638A1 Phthalazinone derivatives
09/29/2010EP2231636A1 Pyrazole derivatives and use thereof as inhibitors of cyclin dependent kinases
1 ... 2071 2072 2073 2074 2075 2076 2077 2078 2079 2080 2081 2082 2083 2084 2085 2086 2087 2088 2089 2090 2091 ... 7860